EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2254
https://www.valueinhealthjournal.com/article/S1098-3015(24)02468-9/fulltext
Title : EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02468-9&doi=10.1016/j.jval.2024.03.2254
First page :
Section Title :
Open access? : No
Section Order : 10243
Categories :
Tags :
Regions :
ViH Article Tags :